Effect of Ranibizumab on Malignant Conjunctival Neoplasia

Clinical trial NCT00456495 · COMPLETED

Trial details

NCT number: NCT00456495
Sponsor: The New York Eye Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Conjunctival Neoplasms

Start date: 2007-03-01
Primary completion: 2010-09-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.